drugset / Trial / NCT06078423
A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)
Phase 3
Completed
1880 enrolled
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Sponsor GmbH · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This trial is a randomized, blind, similar vaccine controlled, single center, non-inferiority design phase III clinical trial, with a study population of 10 to 60 years old, conducted in two stages.Phase 1 and Phase 2
Timeline
- Start
- 2019-10-19
- Primary completion
- 2021-07-21
- Completion
- 2022-09-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Freeze-dried human rabies vaccine (MRC-5 cells) Kanghua | Vaccine | 1 ml | Intramuscular |
| Subject | Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma | Vaccine | 1 ml | Intramuscular |